Evidence map›Paper›PMID 30459860›Full record

ArticleAsian journal of neurosurgery

Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain Injury in Rats: Ultrastructural, Pathological, and Biochemical Analyses.

Askin Esen Hasturk, Emre Cemal Gokce, Erdal Resit Yilmaz, Bahriye Horasanli, Oya Evirgen, Nazli Hayirli, Hilal Gokturk, Imge Erguder, Belgin Can

Open access · hybridAbstract read
In one paragraph

Article in Asian journal of neurosurgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Askin Esen HasturkDepartment of Neurosurgery, Oncology Training and Research Hospital, Ankara, Turkey.
Emre Cemal GokceDepartment of Neurosurgery, Oncology Training and Research Hospital, Ankara, Turkey.
Erdal Resit YilmazDepartment of Neurosurgery, Ministry of Health, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
Bahriye HorasanliDepartment of Neurology, Baskent University Faculty of Medicine, Konya, Turkey.
Oya EvirgenDepartment of Histology and Embryology, Ankara University Faculty of Medicine, Ankara, Turkey.
Nazli HayirliDepartment of Histology and Embryology, Ankara University Faculty of Medicine, Ankara, Turkey.
Hilal GokturkDepartment of Histology and Embryology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey.
Imge ErguderDepartment of Biochemistry, Ankara University Faculty of Medicine, Ankara, Turkey.
Belgin CanDepartment of Histology and Embryology, Ankara University Faculty of Medicine, Ankara, Turkey.
Ankara University · TRMinistry of Health · TRAnkara Yıldırım Beyazıt University · TRBaşkent University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of the present study was to investigate the effect of etanercept (ETA) on histopathological and biochemical changes after traumatic brain injury (TBI) in rats. MATERIALS AND

methodsThirty-six male Wistar albino rats were distributed into three groups (

resultsi.p. administration of ETA at 1 and 6 h significantly reduced inflammatory cytokine expression, attenuated oxidative stress and lipid peroxidation, prevented apoptosis, and increased antioxidant defense mechanism activity in comparison to trauma group. Histopathological and ultrastructural abnormalities were significantly reduced in ETA-treated rats compared to closed head injury trauma groups.

conclusionsETA significantly improves neural function and prevents post-TBI histopathological damage in rats.

Indexed as

Etanerceptrattraumatic brain injurytumor necrosis factor-α antagonist

Identifiers

PMID30459860
PMCPMC6208262
OpenAlexW2802214448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.